Physician
Michele Johnson-Towson MD PA
Michele Johnson-Towson MD PA was paid $3.99M by Medicaid between Aug 2018 and Mar 2023, across 105 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoMICHELE JOHNSON-TOWSON MD PA
TAMPA, FL 33612
TAMPA, FL 33612
33aNPI1033492236assigned 09/23/2011
33bProvider typePediatrics Physician
28Total paid$3.99M
24GClaims148,542
24DCodes billed105
24AFirst – last monthAug 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#86 of 971
Median peer was paid$238K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30 | $0.00 | |
| 2019 | 44,602 | $971K | |
| 2020 | 30,464 | $923K | |
| 2021 | 33,566 | $1.06M | |
| 2022 | 37,105 | $1.04M | |
| 2023 | 2,775 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 28,069 | 20,350 | $1.58M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 7,592 | 6,023 | $567K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.4% | 3,644 | 3,404 | $335K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.7% | 5,335 | 4,823 | $267K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.5% | 2,922 | 2,767 | $261K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.3% | 3,147 | 2,474 | $252K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.0% | 1,872 | 1,799 | $161K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 8,854 | 7,978 | $119K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 3,319 | 2,943 | $64K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.0% | 312 | 277 | $41K |
| 92552 | <1% | 5,642 | 5,337 | $39K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 766 | 699 | $38K |
93 more codes
| 99050 | <1% | 5,731 | $30K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 216 | $26K |
| 99188 | <1% | 4,715 | $25K | |
| 99381 | <1% | 382 | $20K | |
| 94010 | <1% | 3,148 | $19K | |
| 97802 | <1% | 4,704 | $19K | |
| 99383 | <1% | 158 | $13K | |
| 90680 | <1% | 1,256 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,763 | $10K |
| 99058 | <1% | 338 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,322 | $6K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 117 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 889 | $5K |
| 90670 | <1% | 1,848 | $5K | |
| 87631 | <1% | 441 | $5K | |
| 87807 | <1% | 1,451 | $4K | |
| 99384 | <1% | 53 | $4K | |
| 99382 | <1% | 43 | $4K | |
| 83655 | <1% | 1,436 | $4K | |
| 90707 | <1% | 737 | $3K | |
| 90461 | <1% | 2,328 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 57 | $3K |
| 81003 | <1% | 4,187 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 755 | $3K |
| 90473 | <1% | 619 | $2K | |
| 90734 | <1% | 694 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 940 | $2K |
| 94664 | <1% | 778 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,960 | $2K |
| 99401 | <1% | 539 | $1K | |
| 85018 | <1% | 1,439 | $970.66 | |
| 81025 | <1% | 400 | $946.17 | |
| 90651 | <1% | 752 | $907.65 | |
| 0001A | <1% | 74 | $838.11 | |
| 90715 | <1% | 623 | $720.27 | |
| 0072A | <1% | 44 | $720.00 | |
| 90716 | <1% | 737 | $719.90 | |
| 90686 | <1% | 994 | $695.37 | |
| 87428 | <1% | 30 | $693.33 | |
| 0002A | <1% | 63 | $676.21 | |
| 90688 | <1% | 548 | $612.11 | |
| 81000 | <1% | 966 | $576.91 | |
| 99442 | <1% | 42 | $552.47 | |
| 0071A | <1% | 33 | $520.00 | |
| 90710 | <1% | 98 | $445.84 | |
| 81002 | <1% | 769 | $418.00 | |
| 90698 | <1% | 759 | $384.69 | |
| 90672 | <1% | 654 | $373.73 | |
| 87634 | <1% | 70 | $312.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 85 | $233.32 |
| 92587 | <1% | 59 | $231.53 | |
| 92015 | Determination of refractive state | <1% | 42 | $191.91 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 72 | $182.49 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 109 | $160.64 |
| 96127 | <1% | 332 | $157.93 | |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 2,074 | $125.08 |
| 90648 | <1% | 922 | $90.26 | |
| 92551 | <1% | 188 | $89.89 | |
| 90713 | <1% | 747 | $89.02 | |
| 96156 | <1% | 114 | $80.94 | |
| 91300 | <1% | 161 | $78.89 | |
| 90687 | <1% | 194 | $72.84 | |
| 99174 | <1% | 116 | $68.02 | |
| 99177 | <1% | 29 | $54.01 | |
| 90700 | <1% | 1,222 | $45.80 | |
| 99173 | <1% | 91 | $35.50 | |
| 90633 | <1% | 1,171 | $32.03 | |
| 96136 | <1% | 12 | $30.72 | |
| 99051 | <1% | 14 | $30.28 | |
| 94760 | <1% | 1,747 | $28.75 | |
| 90744 | <1% | 900 | $20.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,063 | $16.56 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 13 | $8.02 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 17 | $0.26 |
| 3008F | 0% | 4,514 | $0.00 | |
| 1005F | 0% | 431 | $0.00 | |
| 1111F | 0% | 205 | $0.00 | |
| 1038F | 0% | 207 | $0.00 | |
| D1330 | 0% | 570 | $0.00 | |
| 91307 | 0% | 172 | $0.00 | |
| 2016F | 0% | 45 | $0.00 | |
| 2015F | 0% | 45 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 41 | $0.00 |
| 90620 | 0% | 19 | $0.00 | |
| 36416 | 0% | 52 | $0.00 | |
| D1310 | 0% | 69 | $0.00 | |
| 2014F | 0% | 331 | $0.00 | |
| 4120F | 0% | 169 | $0.00 | |
| 3023F | 0% | 491 | $0.00 | |
| 3210F | 0% | 906 | $0.00 | |
| 4124F | 0% | 544 | $0.00 | |
| 99499 | 0% | 21 | $0.00 | |
| 1116F | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON-TOWSON, MICHELE (OWNER)